These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24723567)

  • 1. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.
    Andersson U; Wibom C; Cederquist K; Aradottir S; Borg A; Armstrong GN; Shete S; Lau CC; Bainbridge MN; Claus EB; Barnholtz-Sloan J; Lai R; Il'yasova D; Houlston RS; Schildkraut J; Bernstein JL; Olson SH; Jenkins RB; Lachance DH; Wrensch M; Davis FG; Merrell R; Johansen C; Sadetzki S; ; Bondy ML; Melin BS
    Neuro Oncol; 2014 Oct; 16(10):1333-40. PubMed ID: 24723567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel germline MLH1 and MSH2 mutations in Latvian Lynch syndrome families.
    Bērziņa D; Irmejs A; Kalniete D; Borošenko V; Nakazawa-Miklaševiča M; Rībenieks K; Trofimovičs G; Gardovskis J; Miklaševičs E
    Exp Oncol; 2012; 34(1):49-52. PubMed ID: 22453149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB
    Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
    Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
    Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of MLH1 and MSH2 mutations in Chilean families with suspected Lynch syndrome.
    Alvarez K; Hurtado C; Hevia MA; Wielandt AM; de la Fuente M; Church J; Carvallo P; López-Köstner F
    Dis Colon Rectum; 2010 Apr; 53(4):450-9. PubMed ID: 20305446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH).
    Staaf J; Törngren T; Rambech E; Johansson U; Persson C; Sellberg G; Tellhed L; Nilbert M; Borg A
    Hum Mutat; 2008 Apr; 29(4):555-64. PubMed ID: 18330910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing.
    Papp J; Kovacs ME; Olah E
    World J Gastroenterol; 2007 May; 13(19):2727-32. PubMed ID: 17569143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study).
    Kurzawski G; Suchy J; Lener M; Kłujszo-Grabowska E; Kładny J; Safranow K; Jakubowska K; Jakubowska A; Huzarski T; Byrski T; Debniak T; Cybulski C; Gronwald J; Oszurek O; Oszutowska D; Kowalska E; Góźdź S; Niepsuj S; Słomski R; Pławski A; Łacka-Wojciechowska A; Rozmiarek A; Fiszer-Maliszewska Ł; Bebenek M; Sorokin D; Sasiadek MM; Stembalska A; Grzebieniak Z; Kilar E; Stawicka M; Godlewski D; Richter P; Brozek I; Wysocka B; Limon J; Jawień A; Banaszkiewicz Z; Janiszewska H; Kowalczyk J; Czudowska D; Scott RJ; Lubiński J
    Clin Genet; 2006 Jan; 69(1):40-7. PubMed ID: 16451135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene.
    Tang R; Hsiung C; Wang JY; Lai CH; Chien HT; Chiu LL; Liu CT; Chen HH; Wang HM; Chen SX; Hsieh LL;
    Clin Genet; 2009 Apr; 75(4):334-45. PubMed ID: 19419416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
    Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
    JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
    Monnerat C; Chompret A; Kannengiesser C; Avril MF; Janin N; Spatz A; Guinebretière JM; Marian C; Barrois M; Boitier F; Lenoir GM; Bressac-de Paillerets B
    Fam Cancer; 2007; 6(4):453-61. PubMed ID: 17624602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turcot syndrome confirmed with molecular analysis.
    Lebrun C; Olschwang S; Jeannin S; Vandenbos F; Sobol H; Frenay M
    Eur J Neurol; 2007 Apr; 14(4):470-2. PubMed ID: 17389002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations.
    Vignoli M; Scaini MC; Ghiorzo P; Sestini R; Bruno W; Menin C; Gensini F; Piazzini M; Testori A; Manoukian S; Orlando C; D'Andrea E; Bianchi-Scarrà G; Genuardi M
    Melanoma Res; 2008 Dec; 18(6):431-7. PubMed ID: 19011513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.
    Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH
    Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.
    Zavodna K; Krivulcik T; Bujalkova MG; Slamka T; Martinicky D; Ilencikova D; Bartosova Z
    BMC Cancer; 2009 Nov; 9():405. PubMed ID: 19930554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel MSH2 mutation in a Chinese family with hereditary non-polyposis colorectal cancer.
    Zheng D; Li T; Liu X; Hu W; Chen H; Yang Y
    Int J Colorectal Dis; 2007 Aug; 22(8):875-9. PubMed ID: 17333219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.
    Martínez-Bouzas C; Ojembarrena E; Beristain E; Errasti J; Viguera N; Tejada Minguéz MI
    Cancer Lett; 2007 Oct; 255(2):295-9. PubMed ID: 17582678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D
    Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.